Exploring the Dynamics of the Clinical Nutrition Market | Registering a CAGR of 6.1% from 2021 to 2028

The global clinical nutrition market size was valued at $32,495.97 million in 2020, and is projected to reach $51,128.26 million by 2028, registering a CAGR of 6.1% from 2021 to 2028.

Drivers, Restraints, and Opportunities:

Factors such as the increasing prevalence of chronic disorders, a growing number of patients utilizing advanced clinical nutritional products, and heightened research and development investments by governments in the healthcare sector are propelling the growth of the global clinical nutrition market. However, the market growth is hampered by factors like lack of awareness and stringent regulations. Nonetheless, advancements in clinical nutrition and untapped potential in emerging countries present new opportunities in the coming years.

Request Sample Report at:

https://www.alliedmarketresearch.com/request-sample/861

COVID-19 Scenario:

During the COVID-19 pandemic, governing authorities such as WHO, ESPEN, ASPEN, and others have issued guidelines regarding the nutritional assessment and screening of hospitalized COVID-19 patients. Nutrition therapy, based on these guidelines and recommendations, has been implemented for all patients, ensuring their nutritional requirements are met adequately.

Key Findings:

The oral segment, in terms of route of administration, accounted for nearly half of the total share of the global clinical nutrition market in 2021 and is expected to maintain its dominance in revenue throughout the forecast period. It is projected to witness the highest CAGR of 5.8% from 2021 to 2028, primarily due to its widespread usage and convenience in treating various diseases.

The cancer segment held the largest market share in 2018, representing nearly one-third of the global clinical nutrition market share. It is anticipated to continue leading during the forecast period, with the highest projected CAGR of 6.0% from 2021 to 2028. This is attributed to the need for nutritional support in cancer patients undergoing various treatments.

North America contributed the highest revenue share in 2018 and is expected to maintain its dominance throughout the forecast period, driven by the rise in chronic diseases in the region. However, Asia-Pacific is poised to witness the fastest CAGR of 6.0% from 2021 to 2028, fueled by an increase in metabolic disorders and growing patient awareness regarding clinical nutrition products.

Leading Market Players:

Abbott Laboratories
B. Braun Melsungen AG
Danone Nutricia
Baxter International Inc.
Fresenius SE & Co. KGaA
Perrigo Company Plc
Pfizer Inc.
Nestlé S.A
Lonza Ltd.
Hero Nutritionals Inc.

For further insights and to purchase the report, visit: https://www.alliedmarketresearch.com/purchase-enquiry/861

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): 1-800-792-5285, 1-503-894-6022, 1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.